Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The company to enhance its ongoing advocacy efforts on drug ingredient quality compliance
Subscribe to our email newsletter
SOCMA has joined an international consortium, which works to enhance security and assure the quality and authenticity of products moving through the drug supply chain.
SOCMA is a non-voting observer member of the consortium, and intends to enhance its ongoing advocacy efforts on drug ingredient quality compliance.
The consortium follows four objectives: adopt standards and best practices to assist in improving the performance of the drug supply chain; develop new technologies that will secure the supply chain and detect tampering; monitor events within the supply chain in order to evaluate their impact; and serve as a platform for the sharing of GMP, GDP and EHS supplier audits in order to reduce the number of audits and increase the effectiveness of those performed.
The Rx-360 Consortium is designed to include the following in its voting membership: biotech firms, pharmaceutical and generic manufacturers, and their suppliers along with third party auditing firms who agree to the membership requirements.